P&G Health shares surge 8% as Q1 revenue jumps 19.5% YoY to Rs 339 crore
P&G Health reported a massive jump in net profit, which stood at ₹66.2 crore, up from ₹16.8 crore in the same quarter last year. Revenue for the quarter rose 19.5% year-on-year to ₹339 crore, compared to ₹283.8 crore in Q1FY25.
The company's EBITDA also witnessed strong growth, rising 89% to ₹90.5 crore from ₹48.2 crore last year. Operating margins expanded to 26.7%, a significant improvement from 17% in the year-ago period.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
3 hours ago
- Business Upturn
ED arrests Ex-Axis Mutual Fund chief dealer Viresh Joshi in over Rs 200 crore front-running case
By Aditya Bhagchandani Published on August 3, 2025, 16:58 IST In a major crackdown on the Axis Mutual Fund front-running scandal, the Enforcement Directorate (ED) has arrested Viresh Gangaram Joshi, the former Chief Dealer of Axis Mutual Fund, under the Prevention of Money Laundering Act (PMLA), 2002. The arrest took place on August 2, 2025, and Joshi has been remanded to ED custody until August 8 for further investigation. The ED conducted search operations on August 1 and 2 across multiple locations including Delhi, Mumbai, Gurugram, Ludhiana, Ahmedabad, Bhavnagar, Bhuj, and Kolkata. These operations stem from an FIR filed by Mumbai Police in December 2024, which alleged that Joshi and others used confidential information about Axis Mutual Fund trades between 2018 and 2021 to execute personal trades ahead of client orders—a practice known as front-running. The investigation has uncovered that Joshi used a trading terminal in Dubai and multiple mule trading accounts to carry out these illicit trades. Several traders and brokers are also under the scanner for exploiting advance trade inputs to generate illegal profits. So far, the ED has identified proceeds of crime worth over Rs 200 crore, a figure that may increase as the probe progresses. As part of the operation, the ED has frozen assets—including shares, mutual fund holdings, and bank balances—worth Rs 17.4 crore. The proceeds were allegedly routed through shell companies and bank accounts linked to the accused and their family members. The ED emphasised that front-running erodes investor trust and undermines market integrity. Axis Mutual Fund currently manages assets worth over Rs 2 lakh crore. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Yahoo
16 hours ago
- Yahoo
NeuroScientific Biopharmaceuticals (ASX:NSB) jumps 14% this week, though earnings growth is still tracking behind one-year shareholder returns
While some are satisfied with an index fund, active investors aim to find truly magnificent investments on the stock market. When you buy and hold the right company, the returns can make a huge difference to both you and your family. For example, the NeuroScientific Biopharmaceuticals Limited (ASX:NSB) share price is up a whopping 576% in the last 1 year, a handsome return in a single year. Also pleasing for shareholders was the 410% gain in the last three months. The longer term returns have not been as good, with the stock price only 6.4% higher than it was three years ago. We love happy stories like this one. The company should be really proud of that performance! On the back of a solid 7-day performance, let's check what role the company's fundamentals have played in driving long term shareholder returns. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. During the last year NeuroScientific Biopharmaceuticals grew its earnings per share (EPS) by 54%. The share price gain of 576% certainly outpaced the EPS growth. So it's fair to assume the market has a higher opinion of the business than it a year ago. The fairly generous P/E ratio of 70.06 also points to this optimism. The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image). This free interactive report on NeuroScientific Biopharmaceuticals' earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further. A Different Perspective We're pleased to report that NeuroScientific Biopharmaceuticals shareholders have received a total shareholder return of 576% over one year. That's better than the annualised return of 1.2% over half a decade, implying that the company is doing better recently. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. To that end, you should learn about the 4 warning signs we've spotted with NeuroScientific Biopharmaceuticals (including 2 which are potentially serious) . For those who like to find winning investments this free list of undervalued companies with recent insider purchasing, could be just the ticket. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Australian exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Upturn
a day ago
- Business Upturn
HPCL signs 10-year LNG supply deal with Abu Dhabi's ALNG
By Aman Shukla Published on August 2, 2025, 20:14 IST Hindustan Petroleum Corporation Limited (HPCL) has entered into a strategic agreement with Abu Dhabi Gas Liquefaction Company (ALNG), a subsidiary of ADNOC Gas, for the long-term supply of Liquefied Natural Gas (LNG) over a 10-year period. The agreement, signed under a Heads of Agreement (HOA), marks a major step in bolstering India's energy security and advancing HPCL's clean energy goals. As per the agreement, HPCL will receive LNG at the newly commissioned Chhara LNG Terminal in Gujarat. The imported LNG will be used to meet the fuel requirements of HPCL's refineries, its City Gas Distribution (CGD) network, and for supplying to downstream customers. ALNG, part of ADNOC Gas, is a globally recognized integrated gas processing and sales company. This collaboration highlights the strengthening energy partnership between India and the UAE, while also supporting India's broader transition toward cleaner fuels. This 10-year LNG procurement deal is expected to play a key role in meeting India's growing energy demands while reducing reliance on more carbon-intensive fuels. It reinforces HPCL's long-term commitment to sustainability and a greener energy future. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
